RT Journal Article
SR Electronic
T1 Dose–response relationship between Frailty Index and Stroke among middle-aged and elderly Chinese
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.28.23292016
DO 10.1101/2023.06.28.23292016
A1 Yang, Yifang
A1 Ma, Yuxia
A1 Yang, Tingting
A1 He, Xiang
A1 Chen, Junbo
A1 Wu, Tingting
A1 Nan, Jinhan
A1 Feng, Juanjuan
A1 Han, Lin
YR 2023
UL http://medrxiv.org/content/early/2023/06/29/2023.06.28.23292016.abstract
AB Background Stroke has emerged as the leading cause of mortality in China, with the burden of the disease increasing with the aging population. Recent research has established a correlation between frailty and stroke, with the frailty index serving as a comprehensive measure of frailty in elderly populations. This study aimed to explore the dose-response relationship between frailty index and stroke, with the objective of providing a reference for effective stroke identification in middle-aged and elderly individuals, thereby preventing the onset of the disease.Methods The data used in this study were derived from the China Health and Retirement Longitudinal Study (CHARLS) database from 2011 to 2018. Proportional hazards model was utilized to investigate the impact of frailty index on stroke risk, while restricted cubic spline analysis was employed to examine the dose-response relationship between frailty index and stroke. Subgroup analysis was used to further understand whether the frailty index has an effect on the occurrence of stroke in different subgroups.Results A total of 11328 participants were included in the study, with 401 (3.3%) stroke patients. Frailty and pre-frailty were associated with a high risk of stroke events compared with robust group (HR, 3.89, 95%CI, 2.88-5.26), (HR, 2.09, 95%CI, 1.60-2.75), after adjusting for all covariates. There was a non-linear relationship between frailty index and stroke in the restricted cubic spline regression model. Frailty index was a risk factor of stroke when it exceeded 0.13. Taking the robust as reference, subgroup analysis results showed a significant interaction with the frailty index in all subgroup analyses except for the smoking group.Conclusion Pre-frailty and frailty were significantly associated with stroke risk. Frailty index had a nonlinear relationship with stroke occurrence, and frailty index >0.13 was significantly correlated with stroke occurrence. Frailty index is an independent predictor of stroke occurrence.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was not a clinical trialFunding StatementThis work was supported by the fund of China Medical Board (grant number #20-374), national scientific research training plan of Gansu Provincial Hospital (grant number 19SYPYA-4), the research funds for the school of nursing of Lanzhou University (grant number LZUSON202002), the Fundamental Research Funds for the Central Universities (grant number lzujbky-2020-10, lzujbky-2021-33), and Natural Science Foundation of Gansu Province (grant number 20JR10RA603).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the Institutional Review Board of Peking University (IRB00001052-11015)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data used in this study were derived from the China Health and Retirement Longitudinal Study (CHARLS) database from 2011 to 2018, The study was approved by the Institutional Review Board of Peking University (IRB00001052-11015), and written informed consent was obtained from all participants or their legal representatives.